<?xml version="1.0" encoding="UTF-8"?><ImplementationGuide xmlns="http://hl7.org/fhir"><id value="cibmtr-reporting"/><url value="http://fhir.nmdp.org/ig/cibmtr-reporting/ImplementationGuide/cibmtr-reporting"/><version value="0.1.5"/><name value="CIBMTRReporting"/><title value="CIBMTR Reporting Implementation Guide"/><status value="draft"/><publisher value="The Medical College of Wisconsin, Inc. and the National Marrow Donor Program"/><contact><name value="The Medical College of Wisconsin, Inc. and the National Marrow Donor Program"/><telecom><system value="url"/><value value="http://www.cibmtr.org"/></telecom></contact><contact><name value="Bob Milius"/><telecom><system value="email"/><value value="bmilius@nmdp.org"/></telecom></contact><description value="How to report HCT data to CIBMTR"/><packageId value="cibmtr-reporting"/><license value="Apache-2.0"/><fhirVersion value="4.0.1"/><dependsOn id="hl7_fhir_us_core"><uri value="http://hl7.org/fhir/us/core/ImplementationGuide/hl7.fhir.us.core"/><packageId value="hl7.fhir.us.core"/><version value="4.0.0"/></dependsOn><dependsOn id="mcode"><uri value="http://hl7.org/fhir/us/mcode/ImplementationGuide/hl7.fhir.us.mcode"/><packageId value="hl7.fhir.us.mcode"/><version value="2.0.0"/></dependsOn><definition><resource><reference><reference value="StructureDefinition/cibmtr-obs-priority-variables"/></reference><name value="CIBMTR Observation Laboratory Results: Priority Variables"/><description value="CIBMTR Observation Laboratory Results: Priority Variables"/><exampleBoolean value="false"/></resource><resource><reference><reference value="StructureDefinition/cibmtr-observation-lab"/></reference><name value="CIBMTR Observation Laboratory Results Profile (us-core)"/><description value="CIBMTR Observation Laboratory Results Profile (us-core)"/><exampleBoolean value="false"/></resource><resource><reference><reference value="StructureDefinition/cibmtr-patient"/></reference><name value="CIBMTR Patient Profile (us-core)"/><description value="CIBMTR Patient Profile for CRID assignment (us-core)"/><exampleBoolean value="false"/></resource><resource><reference><reference value="StructureDefinition/cibmtr-additional-peri-transplant-medication"/></reference><name value="CIBMTR Additional Drugs in Peri-Transplant Period"/><description value="CIBMTR Additional Drugs Given in the Peri-Transplant Period. Drugs may be given during the peri-transplant period to prevent transplant-related complications, such as liver injuries or to facilitate engraftment."/><exampleBoolean value="false"/></resource><resource><reference><reference value="StructureDefinition/cibmtr-gvhd-prophylaxis-medication"/></reference><name value="CIBMTR GVHD Prophylaxis Medication"/><description value="CIBMTR GVHD Prophylaxis Medication"/><exampleBoolean value="false"/></resource><resource><reference><reference value="StructureDefinition/cibmtr-medication"/></reference><name value="CIBMTR Medication (us-core)"/><description value="CIBMTR Medication (us-core)"/><exampleBoolean value="false"/></resource><resource><reference><reference value="StructureDefinition/cibmtr-medication-administration"/></reference><name value="CIBMTR Medication Administration (mcode)"/><description value="CIBMTR Medication Administration (mcode)"/><exampleBoolean value="false"/></resource><resource><reference><reference value="StructureDefinition/cibmtr-medication-dispense"/></reference><name value="CIBMTR Medication Dispense"/><description value="CIBMTR Medication Dispense"/><exampleBoolean value="false"/></resource><resource><reference><reference value="StructureDefinition/cibmtr-medication-request"/></reference><name value="CIBMTR Medication Request (mcode)"/><description value="CIBMTR Medication Request (mcode)"/><exampleBoolean value="false"/></resource><resource><reference><reference value="StructureDefinition/cibmtr-mobilizing-agent-medication"/></reference><name value="CIBMTR Mobilizing Agent Medication"/><description value="CIBMTR Moblizing Agents (auto only) Medication"/><exampleBoolean value="false"/></resource><resource><reference><reference value="StructureDefinition/cibmtr-post-hct-disease-therapy-planned-medication"/></reference><name value="CIBMTR Planned Post-HCT Disease Therapy Medication"/><description value="CIBMTR Planned Post-HCT Disease Therapy Medication"/><exampleBoolean value="false"/></resource><resource><reference><reference value="StructureDefinition/cibmtr-prep-regimen-medication"/></reference><name value="CIBMTR Prep Regimen Medication"/><description value="CIBMTR Pre-HCT Preparative Regimen (Conditioning) Medication"/><exampleBoolean value="false"/></resource><resource><reference><reference value="StructureDefinition/cibmtr-prior-exposure-medication"/></reference><name value="CIBMTR Prior Exposure Medication"/><description value="CIBMTR Prior Exposure: Potential Study Eligibility Medication"/><exampleBoolean value="false"/></resource><resource><reference><reference value="ValueSet/auto-differential-blood-vs"/></reference><name value="Auto Differential panel - Blood (57023-4)"/><description value="Auto Differential panel - Blood (57023-4)"/><exampleBoolean value="false"/></resource><resource><reference><reference value="ValueSet/cbc-blood-automated-vs"/></reference><name value="CBC panel - Blood by Automated count (58410-2)"/><description value="CBC panel - Blood by Automated count (58410-2)"/><exampleBoolean value="false"/></resource><resource><reference><reference value="ValueSet/cbc-w-auto-differential-blood-vs"/></reference><name value="CBC W Auto Differential panel - Blood (57021-8)"/><description value="CBC W Auto Differential panel - Blood (57021-8)"/><exampleBoolean value="false"/></resource><resource><reference><reference value="ValueSet/cbc-w-differential-unspecified-blood-vs"/></reference><name value="CBC W Differential panel, method unspecified - Blood (69742-5)"/><description value="CBC W Differential panel, method unspecified - Blood (69742-5)"/><exampleBoolean value="false"/></resource><resource><reference><reference value="ValueSet/cbc-w-ordered-manual-differential-blood-vs"/></reference><name value="CBC W Ordered Manual Differential panel - Blood (57782-5)"/><description value="CBC W Ordered Manual Differential panel - Blood (57782-5)"/><exampleBoolean value="false"/></resource><resource><reference><reference value="ValueSet/differential-unspecified-blood-vs"/></reference><name value="Differential panel, method unspecified - Blood (69738-3)"/><description value="Differential panel, method unspecified - Blood (69738-3)"/><exampleBoolean value="false"/></resource><resource><reference><reference value="ValueSet/erythrocyte-morphology-blood-vs"/></reference><name value="Erythrocyte morphology panel - Blood (58408-6)"/><description value="Erythrocyte morphology panel - Blood (58408-6)"/><exampleBoolean value="false"/></resource><resource><reference><reference value="ValueSet/gvhdtype-valueset"/></reference><name value="GVHD Type Value Set"/><description value="Permissible values for types of Graft vs Host Disease, from NIH caDSR"/><exampleBoolean value="false"/></resource><resource><reference><reference value="ValueSet/hematopoietic-disorder-vs"/></reference><name value="Disorders of hematopoietic structure"/><description value="SNOMED: Disorders of hematopoietic structure"/><exampleBoolean value="false"/></resource><resource><reference><reference value="ValueSet/leukocyte-morphology-blood-vs"/></reference><name value="Leukocyte morphology panel - Blood (58407-8)"/><description value="Leukocyte morphology panel - Blood (58407-8)"/><exampleBoolean value="false"/></resource><resource><reference><reference value="ValueSet/manual-differential-blood-vs"/></reference><name value="Manual Differential panel - Blood (24318-8)"/><description value="Manual Differential panel - Blood (24318-8)"/><exampleBoolean value="false"/></resource><resource><reference><reference value="ValueSet/platelet-morphology-blood-vs"/></reference><name value="Platelet morphology panel - Blood (58406-0)"/><description value="Platelet morphology panel - Blood (58406-0)"/><exampleBoolean value="false"/></resource><resource><reference><reference value="ValueSet/presence-valueset"/></reference><name value="Presence Answer List"/><description value="Permissible values for presence"/><exampleBoolean value="false"/></resource><resource><reference><reference value="ValueSet/cibmtr-priority-variables-2021"/></reference><name value="CIBMTR Priority Variables Value Set (FY21)"/><description value="Priority Variables for CIBMTR (FY21)"/><exampleBoolean value="false"/></resource><resource><reference><reference value="ValueSet/cibmtr-priority-variables-2022"/></reference><name value="CIBMTR Priority Variables Value Set (FY22)"/><description value="Priority Variables for CIBMTR (FY22)"/><exampleBoolean value="false"/></resource><resource><reference><reference value="ValueSet/cibmtr-priority-variables-epic-2021"/></reference><name value="CIBMTR Priority Variables Value Set for Epic App (FY21)"/><description value="Priority Variables for Epic CIBMTR Reporting App (FY21)"/><exampleBoolean value="false"/></resource><resource><reference><reference value="ValueSet/med-addition-peri-transplant-vs"/></reference><name value="RxNorm - Additional Drugs in Peri-Transplant Period"/><description value="RxNorm codes for Additional Drugs in Peri-Transplant Period"/><exampleBoolean value="false"/></resource><resource><reference><reference value="ValueSet/med-alemtuzumab-vs"/></reference><name value="RxNorm - Alemtuzumab"/><description value="RxNorm codes for Alemtuzumab"/><exampleBoolean value="false"/></resource><resource><reference><reference value="ValueSet/med-all-form2400-vs"/></reference><name value="RxNorm - All of Form 2400"/><description value="RxNorm codes for all of Form 2400"/><exampleBoolean value="false"/></resource><resource><reference><reference value="ValueSet/med-anti-thymocyte-globulin-vs"/></reference><name value="RxNorm - Anti-Thymocyte Globulin"/><description value="RxNorm codes for Anti-Thymocyte Globulin"/><exampleBoolean value="false"/></resource><resource><reference><reference value="ValueSet/med-bortezomib-vs"/></reference><name value="RxNorm - Bortezomib"/><description value="RxNorm codes for Bortezomib"/><exampleBoolean value="false"/></resource><resource><reference><reference value="ValueSet/med-busulfan-vs"/></reference><name value="RxNorm - Busulfan"/><description value="RxNorm codes for Busulfan"/><exampleBoolean value="false"/></resource><resource><reference><reference value="ValueSet/med-carmustine-vs"/></reference><name value="RxNorm - Carmustine"/><description value="RxNorm codes for Carmustine"/><exampleBoolean value="false"/></resource><resource><reference><reference value="ValueSet/med-cyclophosphamide-vs"/></reference><name value="RxNorm - Cyclophosphamide"/><description value="RxNorm codes for Cyclophosphamide "/><exampleBoolean value="false"/></resource><resource><reference><reference value="ValueSet/med-cytarabine-vs"/></reference><name value="RxNorm - Cytarabine"/><description value="RxNorm codes for Cytarabine"/><exampleBoolean value="false"/></resource><resource><reference><reference value="ValueSet/med-defibrotide-vs"/></reference><name value="RxNorm - Defibrotide"/><description value="RxNorm codes for Defibrotide"/><exampleBoolean value="false"/></resource><resource><reference><reference value="ValueSet/med-etoposide-vs"/></reference><name value="RxNorm - Etoposide"/><description value="RxNorm codes for Etoposide "/><exampleBoolean value="false"/></resource><resource><reference><reference value="ValueSet/med-fludarabine-vs"/></reference><name value="RxNorm - Fludarabine"/><description value="RxNorm codes for Fludarabine "/><exampleBoolean value="false"/></resource><resource><reference><reference value="ValueSet/med-gvhd-prophylaxis-vs"/></reference><name value="RxNorm - GVHD Prophylaxis"/><description value="RxNorm codes for GVHD Prophylaxis"/><exampleBoolean value="false"/></resource><resource><reference><reference value="ValueSet/med-melphalan-vs"/></reference><name value="RxNorm - Melphalan"/><description value="RxNorm codes for Melphalan "/><exampleBoolean value="false"/></resource><resource><reference><reference value="ValueSet/med-mobilizing-agents-vs"/></reference><name value="RxNorm - Mobilizing Agents (auto only)"/><description value="RxNorm codes for Mobilizing Agents (auto only)"/><exampleBoolean value="false"/></resource><resource><reference><reference value="ValueSet/med-post-hct-disease-therapy-planned-vs"/></reference><name value="RxNorm - Post-HCT Disease Therapy Planned"/><description value="RxNorm codes for Post-HCT Disease Therapy Planned"/><exampleBoolean value="false"/></resource><resource><reference><reference value="ValueSet/med-prep-regimen-vs"/></reference><name value="RxNorm - Prep Regimen"/><description value="RxNorm codes for Prep Regimen"/><exampleBoolean value="false"/></resource><resource><reference><reference value="ValueSet/med-prior-exposure-vs"/></reference><name value="RxNorm - Prior Exposure: Potential Study Eligibility"/><description value="Prior Exposure: Potential Study Eligibility"/><exampleBoolean value="false"/></resource><resource><reference><reference value="ValueSet/med-rituximab-vs"/></reference><name value="RxNorm - Rituximab"/><description value="RxNorm codes for Rituximab"/><exampleBoolean value="false"/></resource><resource><reference><reference value="ValueSet/med-thiotepa-vs"/></reference><name value="RxNorm - Thiotepa"/><description value="RxNorm codes for Thiotepa"/><exampleBoolean value="false"/></resource><resource><reference><reference value="ValueSet/med-treosulfan-vs"/></reference><name value="RxNorm - Treosulfan"/><description value="RxNorm codes for Treosulfan"/><exampleBoolean value="false"/></resource><resource><reference><reference value="ValueSet/med-ursodiol-vs"/></reference><name value="RxNorm - Ursodiol"/><description value="RxNorm codes for Ursodiol"/><exampleBoolean value="false"/></resource><resource><reference><reference value="ValueSet/snomed-myelodysplastic-diseases-vs"/></reference><name value="SNOMED Myelodysplastic Diseases"/><description value="The myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell diseases characterized by cytopenia(s), dysplasia (abnormal growth or development leading to an alteration in size, shape, and organization of the cell) in one or more of the major myeloid cell lines (WBC, RBC, and/or platelets), ineffective hematopoiesis, and an increased risk of developing acute myelogenous leukemia (AML). MDS occurs primarily in older adults, with a median age of 70 years. The majority of recipients present with symptoms related to cytopenias. Most recipients present with anemia requiring RBC transfusions."/><exampleBoolean value="false"/></resource><resource><reference><reference value="ValueSet/smear-morphology-blood-vs"/></reference><name value="Smear morphology panel - Blood (34994-4)"/><description value="Smear morphology panel - Blood (34994-4)"/><exampleBoolean value="false"/></resource><resource><reference><reference value="CodeSystem/cibmtr-cadsr-cde"/></reference><name value="NIH Common Data Elements for CIBMTR"/><description value="NIH Common Data Elements for CIBMTR"/><exampleBoolean value="false"/></resource><resource><reference><reference value="CodeSystem/cibmtr-cadsr-vm"/></reference><name value="NIH Common Data Element Value Meanings for CIBMTR"/><description value="NIH Common Data Element Value Meanings for CIBMTR"/><exampleBoolean value="false"/></resource><resource><reference><reference value="Observation/ABOBloodGroupObservationLOINC"/></reference><name value="ABOBloodGroupObservationLOINC"/><description value="ABO group [Type] in Blood (883-9) with LOINC answer"/><exampleCanonical value="http://fhir.nmdp.org/ig/cibmtr-reporting/StructureDefinition/cibmtr-obs-priority-variables"/></resource><resource><reference><reference value="Observation/ABOBloodGroupObservationSNOMED"/></reference><name value="ABOBloodGroupObservationSNOMED"/><description value="ABO group [Type] in Blood (883-9) with SNOMED answer"/><exampleCanonical value="http://fhir.nmdp.org/ig/cibmtr-reporting/StructureDefinition/cibmtr-obs-priority-variables"/></resource><resource><reference><reference value="Observation/ABORhObservationLOINC"/></reference><name value="ABORhObservationLOINC"/><description value="ABO and Rh group [Type] in Blood (882-1) with LOINC answer"/><exampleCanonical value="http://fhir.nmdp.org/ig/cibmtr-reporting/StructureDefinition/cibmtr-obs-priority-variables"/></resource><resource><reference><reference value="Observation/ABORhObservationSNOMED"/></reference><name value="ABORhObservationSNOMED"/><description value="ABO and Rh group [Type] in Blood (882-1) with SNOMED CT answer"/><exampleCanonical value="http://fhir.nmdp.org/ig/cibmtr-reporting/StructureDefinition/cibmtr-obs-priority-variables"/></resource><resource><reference><reference value="Observation/AlbuminObservation"/></reference><name value="AlbuminObservation"/><description value="Albumin [Mass/volume] in Serum or Plasma"/><exampleCanonical value="http://fhir.nmdp.org/ig/cibmtr-reporting/StructureDefinition/cibmtr-obs-priority-variables"/></resource><resource><reference><reference value="Observation/BasophilsObservation"/></reference><name value="BasophilsObservation"/><description value="Basophils/100 leukocytes in Blood"/><exampleCanonical value="http://fhir.nmdp.org/ig/cibmtr-reporting/StructureDefinition/cibmtr-obs-priority-variables"/></resource><resource><reference><reference value="Observation/CMVDNAViralLoadCopiesmL"/></reference><name value="CMVDNAViralLoadCopiesmL"/><description value="Cytomegalovirus DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection (49349-4)"/><exampleCanonical value="http://fhir.nmdp.org/ig/cibmtr-reporting/StructureDefinition/cibmtr-obs-priority-variables"/></resource><resource><reference><reference value="Observation/CMVDNAViralLoadIUmL"/></reference><name value="CMVDNAViralLoadIUmL"/><description value="Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection (72493-0)"/><exampleCanonical value="http://fhir.nmdp.org/ig/cibmtr-reporting/StructureDefinition/cibmtr-obs-priority-variables"/></resource><resource><reference><reference value="Observation/CMVIgAbPresenceSNOMED"/></reference><name value="CMVIgAbPresenceSNOMED"/><description value="Cytomegalovirus IgG Ab [Presence] in Serum or Plasma by Immunoassay (13949-3) with SNOMED CT answer"/><exampleCanonical value="http://fhir.nmdp.org/ig/cibmtr-reporting/StructureDefinition/cibmtr-obs-priority-variables"/></resource><resource><reference><reference value="Observation/CMVIgGAbPresenceLOINC"/></reference><name value="CMVIgGAbPresenceLOINC"/><description value="Cytomegalovirus IgG Ab [Presence] in Serum or Plasma by Immunoassay (13949-3) with LOINC answer"/><exampleCanonical value="http://fhir.nmdp.org/ig/cibmtr-reporting/StructureDefinition/cibmtr-obs-priority-variables"/></resource><resource><reference><reference value="Observation/CMVIgMAbPresenceLOINC"/></reference><name value="CMVIgMAbPresenceLOINC"/><description value="Cytomegalovirus IgM Ab [Presence] in Serum or Plasma by Immunoassay (24119-0) with LOINC answer"/><exampleCanonical value="http://fhir.nmdp.org/ig/cibmtr-reporting/StructureDefinition/cibmtr-obs-priority-variables"/></resource><resource><reference><reference value="Observation/CMVIgMAbPresenceSNOMED"/></reference><name value="CMVIgMAbPresenceSNOMED"/><description value="Cytomegalovirus IgM Ab [Presence] in Serum or Plasma by Immunoassay (24119-0) with SNOMED answer"/><exampleCanonical value="http://fhir.nmdp.org/ig/cibmtr-reporting/StructureDefinition/cibmtr-obs-priority-variables"/></resource><resource><reference><reference value="Observation/EosinophilsObservation"/></reference><name value="EosinophilsObservation"/><description value="Eosinophils observation, #/volume in Blood"/><exampleCanonical value="http://fhir.nmdp.org/ig/cibmtr-reporting/StructureDefinition/cibmtr-obs-priority-variables"/></resource><resource><reference><reference value="Observation/HemoglobinObservation"/></reference><name value="HemoglobinObservation"/><description value="Hemoglobin [Mass/volume] in Blood"/><exampleCanonical value="http://fhir.nmdp.org/ig/cibmtr-reporting/StructureDefinition/cibmtr-obs-priority-variables"/></resource><resource><reference><reference value="Observation/LeukocytesObservation"/></reference><name value="LeukocytesObservation"/><description value="Leukocytes observation"/><exampleCanonical value="http://fhir.nmdp.org/ig/cibmtr-reporting/StructureDefinition/cibmtr-observation-lab"/></resource><resource><reference><reference value="Observation/MetamyelocytesObservation"/></reference><name value="MetamyelocytesObservation"/><description value="Metamyelocytes [Presence] in Blood"/><exampleCanonical value="http://fhir.nmdp.org/ig/cibmtr-reporting/StructureDefinition/cibmtr-obs-priority-variables"/></resource><resource><reference><reference value="Observation/NeutrophilsObservation"/></reference><name value="NeutrophilsObservation"/><description value="Neutrophils [#/volume] in Cord blood"/><exampleCanonical value="http://fhir.nmdp.org/ig/cibmtr-reporting/StructureDefinition/cibmtr-obs-priority-variables"/></resource><resource><reference><reference value="Patient/PatientExample1"/></reference><name value="PatientExample1"/><description value="example using CIBMTR center number"/><exampleCanonical value="http://fhir.nmdp.org/ig/cibmtr-reporting/StructureDefinition/cibmtr-patient"/></resource><resource><reference><reference value="Patient/PatientExample2"/></reference><name value="PatientExample2"/><description value="Patient with CIBMTR CRID"/><exampleCanonical value="http://fhir.nmdp.org/ig/cibmtr-reporting/StructureDefinition/cibmtr-patient"/></resource><resource><reference><reference value="Patient/PatientExample3"/></reference><name value="PatientExample3"/><description value="Patient with MRN and CRID, Race=White, Ethnicity=Unknown"/><exampleCanonical value="http://fhir.nmdp.org/ig/cibmtr-reporting/StructureDefinition/cibmtr-patient"/></resource><resource><reference><reference value="Patient/PatientExample4"/></reference><name value="PatientExample4"/><description value="Patient with CRID and MRN, Race=Black or African American, Ethnicity=Unknown"/><exampleCanonical value="http://fhir.nmdp.org/ig/cibmtr-reporting/StructureDefinition/cibmtr-patient"/></resource><resource><reference><reference value="Patient/PatientExample5"/></reference><name value="PatientExample5"/><description value="Patient with CRID &amp; MRN, Race=Mixed, Ethnicity=Not Hispanic or Latino"/><exampleCanonical value="http://fhir.nmdp.org/ig/cibmtr-reporting/StructureDefinition/cibmtr-patient"/></resource><resource><reference><reference value="Patient/PatientExample6"/></reference><name value="PatientExample6"/><description value="Patient with CIBMTR CRID"/><exampleCanonical value="http://fhir.nmdp.org/ig/cibmtr-reporting/StructureDefinition/cibmtr-patient"/></resource><page><nameUrl value="toc.html"/><title value="Table of Contents"/><generation value="html"/><page><nameUrl value="index.html"/><title value="Home"/><generation value="markdown"/></page><page><nameUrl value="Access-Credentials.html"/><title value="Access Credentials"/><generation value="markdown"/></page><page><nameUrl value="Bundles.html"/><title value="Bundles"/><generation value="markdown"/></page><page><nameUrl value="Connection-Guide-R4.html"/><title value="Connection Guide R 4"/><generation value="markdown"/></page><page><nameUrl value="CRID-Assignment.html"/><title value="CRID Assignment"/><generation value="markdown"/></page><page><nameUrl value="Direct-FHIR-STU3.html"/><title value="Direct FHIR STU 3"/><generation value="html"/></page><page><nameUrl value="Endpoints.html"/><title value="Endpoints"/><generation value="markdown"/></page><page><nameUrl value="Example-Code.html"/><title value="Example Code"/><generation value="markdown"/></page><page><nameUrl value="Form-2450.html"/><title value="Form 2450"/><generation value="markdown"/></page><page><nameUrl value="Laboratory-Observations.html"/><title value="Laboratory Observations"/><generation value="markdown"/></page><page><nameUrl value="Medications.html"/><title value="Medications"/><generation value="markdown"/></page><page><nameUrl value="Patient.html"/><title value="Patient"/><generation value="markdown"/></page></page><parameter><code value="copyrightyear"/><value value="2020+"/></parameter><parameter><code value="releaselabel"/><value value="Trial Use 1"/></parameter><parameter><code value="show-inherited-invariants"/><value value="false"/></parameter></definition></ImplementationGuide>